A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases
Clinical trial NCT04338685 · COMPLETED
Trial details
- NCT number
- NCT04338685
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2023-01-09
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.